Inventor

MITNACHT-KRAUS RITA

DE16 patents

⚠️ This page may combine multiple inventors who share the name “MITNACHT-KRAUS RITA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GANYMED PHARMACEUTICALS AG

9 patents

US10053512B2Aug 21, 2018

Antibodies against claudin 18.2 useful in cancer diagnosis

GANYMED PHARMACEUTICALS AG6 citations83

US10314890B2Jun 11, 2019

Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer

GANYMED PHARMACEUTICALS AG5 citations82

US9770487B2Sep 26, 2017

Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic adenocarcinoma

GANYMED PHARMACEUTICALS AG11 citations82

US9512232B2Dec 6, 2016

Antibodies against Claudin 18.2 useful in cancer diagnosis

GANYMED PHARMACEUTICALS AG9 citations82

US10813996B2Oct 27, 2020

Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer

GANYMED PHARMACEUTICALS AG4 citations81

US9433675B2Sep 6, 2016

Combination therapy involving antibodies against claudin 18.2 for treatment of cancer

GANYMED PHARMACEUTICALS AG5 citations81

US10022444B2Jul 17, 2018

Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer

GANYMED PHARMACEUTICALS AG2 citations70

US11976130B2May 7, 2024

Antibodies against claudin 18.2 useful in cancer diagnosis

GANYMED PHARMACEUTICALS AG0 citations62

US10596256B2Mar 24, 2020

Monoclonal anti-GT 468 antibodies for treatment of cancer

GANYMED PHARMACEUTICALS AG0 citations52

ASTELLAS PHARMA INC

5 patents

US11919951B2Mar 5, 2024

Antibodies useful in cancer diagnosis

ASTELLAS PHARMA INC0 citations61

US11826402B2Nov 28, 2023

Combination therapy involving antibodies against claudin 18.2 for treatment of metastatic pancreatic adenocarcinoma

ASTELLAS PHARMA INC0 citations61

US11279757B2Mar 22, 2022

Antibodies useful in cancer diagnosis

ASTELLAS PHARMA INC0 citations61

US10946069B2Mar 16, 2021

Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer

ASTELLAS PHARMA INC0 citations61

US12059464B2Aug 13, 2024

Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer

ASTELLAS PHARMA INC0 citations59

SAHIN UGUR

1 patent

US8946388B2Feb 3, 2015

Monoclonal antibodies for treatment of cancer

SAHIN UGUR41 citations94

GANYMED PHARMACEUTICALS GMBH

1 patent

US11541127B2Jan 3, 2023

Drug conjugates comprising antibodies against claudin 18.2

GANYMED PHARMACEUTICALS GMBH2 citations71